QQ客服 官方微博 反馈留言

浏览/检索结果: 共7条，第1-7条 帮助 限定条件 发表日期：2021     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 The methyltransferase METTL3 negatively regulates nonalcoholic steatohepatitis (NASH) progression 期刊论文 NATURE COMMUNICATIONS, 2021, 卷号: 12, 期号: 1, 页码: 17 作者:  Li, Xinzhi;  Yuan, Bingchuan;  Lu, Min;  Wang, Yuqin;  Ding, Na 收藏  |  浏览/下载：37/0  |  提交时间：2022/01/18 DRAK2 aggravates nonalcoholic fatty liver disease progression through SRSF6-associated RNA alternative splicing 期刊论文 CELL METABOLISM, 2021, 卷号: 33, 期号: 10, 页码: 2004-+ 作者:  Li, Yufeng;  Xu, Junyu;  Lu, Yuting;  Bian, Hua;  Yang, Lin 收藏  |  浏览/下载：23/0  |  提交时间：2022/01/18 Histone deacetylase inhibitor givinostat attenuates nonalcoholic steatohepatitis and liver fibrosis 期刊论文 ACTA PHARMACOLOGICA SINICA, 2021, 页码: 13 作者:  Huang, He-ming;  Fan, Shi-jie;  Zhou, Xiao-ru;  Liu, Yan-jun;  Li, Xiao 收藏  |  浏览/下载：58/0  |  提交时间：2021/11/04 nonalcoholic steatohepatitis  inflammation  histone deacetylase inhibitor  givinostat  epigenetics   Discovery of novel ketoxime ether derivatives with potent FXR agonistic activity, oral effectiveness and high liver/blood ratio 期刊论文 BIOORGANIC & MEDICINAL CHEMISTRY, 2021, 卷号: 43, 页码: 13 作者:  Tang, Xuehang;  Ning, Mengmeng;  Ye, Yangliang;  Gu, Yipei;  Yan, Hongyi 收藏  |  浏览/下载：49/0  |  提交时间：2021/11/04 FXR agonist  Ketoxime ether  Target genes  Liver  blood ratio  Systemic activation   A new mechanism of obeticholic acid on NASH treatment by inhibiting NLRP3 inflammasome activation in macrophage 期刊论文 METABOLISM-CLINICAL AND EXPERIMENTAL, 2021, 卷号: 120, 页码: 12 作者:  Huang, Suling;  Wu, Yanwei;  Zhao, Zhuohui;  Wu, Bing;  Sun, Kai 收藏  |  浏览/下载：90/0  |  提交时间：2021/08/17 Macrophage  NLRP3 inflammasome  Hepatic lipid accumulation  NASH  FXR   Combined treatment with FABP4 inhibitor ameliorates rosiglitazone-induced liver steatosis in obese diabetic db/db mice 期刊论文 BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2021, 页码: 10 作者:  Chen, Meng-Ting;  Huang, Jun-Shang;  Gao, Ding-Ding;  Li, Ying-Xia;  Wang, He-Yao 收藏  |  浏览/下载：41/0  |  提交时间：2021/08/17 combined treatment  FABP4 inhibitor  liver steatosis  obese type 2 diabetes  rosiglitazone   Activating Adenosine Monophosphate-Activated Protein Kinase Mediates Fibroblast Growth Factor 1 Protection From Nonalcoholic Fatty Liver Disease in Mice 期刊论文 HEPATOLOGY, 2021, 卷号: 73, 期号: 6, 页码: 2206-2222 作者:  Lin, Qian;  Huang, Zhifeng;  Cai, Genxiang;  Fan, Xia;  Yan, Xiaoqing 收藏  |  浏览/下载：34/0  |  提交时间：2021/08/17